Work

Ramucirumab treatment in patients with gastric cancer/gastroesophageal junction adenocarcinoma: Secondary analysis of efficacy and safety results of 4 dosing regimens in the phase II trial I4T-MC-JVDB.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.4_suppl.117

Authors: Jaffer A. Ajani, Anghel Adrian Udrea, Tomasz Sarosiek, Michael Schenker, Carys Morgan, Joanna Pikiel, Mano Joseph, Tomas Salek, Christophe Tournigand, David Raymond Ferry, Yawei Zhang, Amanda Long, Wen-Ling Kuo, Ling Gao, Francesca Russo, Wasat Mansoor

Institutions: The University of Texas MD Anderson Cancer Center, Velindre Cancer Centre, New Cross Hospital, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Henri-Mondor, Eli Lilly (United States), Eli Lilly (Italy), The Christie Hospital, The Christie NHS Foundation Trust

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2790288546

Cites:

Cited by: 3

Related to: 10